Victory Capital Management’s Celyad Oncology SA American Depositary Shares CYAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-79,902
| Closed | -$419K | – | 2871 |
|
|
2021
Q2 | $419K | Sell |
79,902
-670,014
| -89% | -$3.51M | ﹤0.01% | 2289 |
|
|
2021
Q1 | $5.23M | Sell |
749,916
-40,890
| -5% | -$285K | 0.01% | 1320 |
|
|
2020
Q4 | $6.17M | Sell |
790,806
-44,161
| -5% | -$344K | 0.01% | 1188 |
|
|
2020
Q3 | $8.33M | Buy |
834,967
+50,227
| +6% | +$501K | 0.01% | 1078 |
|
|
2020
Q2 | $8.52M | Sell |
784,740
-1,200,976
| -60% | -$13M | 0.01% | 1052 |
|
|
2020
Q1 | $14.5M | Buy |
1,985,716
+986,277
| +99% | +$7.21M | 0.01% | 982 |
|
|
2019
Q4 | $10.4M | Buy |
999,439
+45,778
| +5% | +$477K | 0.01% | 997 |
|
|
2019
Q3 | $9.62M | Buy |
953,661
+263,480
| +38% | +$2.66M | 0.01% | 997 |
|
|
2019
Q2 | $7.92M | Buy |
690,181
+17,850
| +3% | +$205K | 0.02% | 816 |
|
|
2019
Q1 | $13.7M | Buy |
672,331
+25,980
| +4% | +$530K | 0.03% | 658 |
|
|
2018
Q4 | $11.7M | Buy |
646,351
+25,189
| +4% | +$457K | 0.03% | 682 |
|
|
2018
Q3 | $16.4M | Buy |
621,162
+17,160
| +3% | +$452K | 0.03% | 657 |
|
|
2018
Q2 | $18.7M | Buy |
604,002
+178,380
| +42% | +$5.53M | 0.04% | 617 |
|
|
2018
Q1 | $14.6M | Sell |
425,622
-18,280
| -4% | -$627K | 0.03% | 658 |
|
|
2017
Q4 | $19.5M | Buy |
443,902
+118,590
| +36% | +$5.2M | 0.04% | 587 |
|
|
2017
Q3 | $18.2M | Sell |
325,312
-47,280
| -13% | -$2.65M | 0.04% | 609 |
|
|
2017
Q2 | $15.8M | Sell |
372,592
-1,901
| -0.5% | -$80.6K | 0.04% | 629 |
|
|
2017
Q1 | $9.99M | Buy |
374,493
+22,600
| +6% | +$603K | 0.02% | 691 |
|
|
2016
Q4 | $6.33M | Buy |
351,893
+580
| +0.2% | +$10.4K | 0.02% | 746 |
|
|
2016
Q3 | $8.29M | Buy |
+351,313
| New | +$8.29M | 0.02% | 690 |
|